menu
    • menu

    Company profile for Checkpoint Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Checkpoint Therapeutics, Inc. (“Checkpoint”) is a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers. Checkpoint is evaluating its lead small-molecule, targeted anti-cancer agent, CK-101, in a Phase 1/2 clinical trial for the treatment of patients with EGFR mutation-positive non-small cell lung can...
    Checkpoint Therapeutics, Inc. (“Checkpoint”) is a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers. Checkpoint is evaluating its lead small-molecule, targeted anti-cancer agent, CK-101, in a Phase 1/2 clinical trial for the treatment of patients with EGFR mutation-positive non-small cell lung cancer (“NSCLC”).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Checkpoint TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2 Gansevoort Street 9th Floor New York, NY 10014
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://checkpointtx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Exelixis: Zanzalintinib Combo Boosts OS in Colorectal Cancer
    Exelixis: Zanzalintinib Combo Boosts OS in Colorectal Cancer

    22 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250622399674/en/Exelixis-Announces-Zanzalintinib-in-Combination-with-an-Immune-Checkpoint-Inhibitor-Improved-Overall-Survival-in-STELLAR-303-Phase-3-Pivotal-Trial-in-Patients-with-Metastatic-Colorectal-Cancer

    BUSINESSWIRE
    22 Jun 2025
    Share Share
    Fortress Biotech Closes Sale of Checkpoint Therapeutics
    Fortress Biotech Closes Sale of Checkpoint Therapeutics

    30 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/30/3091157/28889/en/Fortress-Biotech-Announces-Closing-of-Sale-of-Subsidiary-Checkpoint-Therapeutics.html

    GLOBENEWSWIRE
    30 May 2025
    Share Share
    Sun Pharma Completes its Acquisition of Checkpoint Therapeutics
    Sun Pharma Completes its Acquisition of Checkpoint Therapeutics

    30 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sun-pharma-completes-its-acquisition-of-checkpoint-therapeutics-302469542.html

    PR NEWSWIRE
    30 May 2025
    Share Share
    Checkpoint Therapeutics Reports Q1 Financial Results and Updates
    Checkpoint Therapeutics Reports Q1 Financial Results and Updates

    13 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/13/3080676/36989/en/Checkpoint-Therapeutics-Reports-First-Quarter-Financial-Results-and-Recent-Corporate-Updates.html

    GLOBENEWSWIRE
    13 May 2025
    Share Share
    Checkpoint Therapeutics Reports 2024 Financial Results & Updates
    Checkpoint Therapeutics Reports 2024 Financial Results & Updates

    28 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/28/3051364/36989/en/Checkpoint-Therapeutics-Reports-Full-Year-2024-Financial-Results-and-Recent-Corporate-Updates.html

    GLOBENEWSWIRE
    28 Mar 2025
    Share Share
    Sun Pharma to Acquire Checkpoint Therapeutics
    Sun Pharma to Acquire Checkpoint Therapeutics

    10 Mar 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/indias-sun-pharma-acquire-checkpoint-therapeutics-2025-03-10/

    REUTERS
    10 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search